ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

In Brief: NCI, EPA Award contract For Farmers study To Iowa, North Carolina; NIAID’s Hoth to Resign

January 29, 1993

Funding Opportunities

September 27, 2002

NCI to Fund research In Tobacco Use Prevention In Youth

December 6, 1996

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987